To the central content area
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

1788 HCI
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
LEE, CHUNG-LIANG CHEN KUO SHIH LEE, YING-FEN 6626-1166 8F.2,NO.2,Ln.609,Sec.5,Chongxin Rd.,Sanchong Dist.,New Taipei City 24159,TaiwaR.O.C. 2009/07/20
Industry Main Business
Biotechnology and Medical Care In 1989, sold only TORAY hemodialysis products, imported equipments and consumables for sale and service. Beginning in 1994 and 1995, imported new dialyzers from TERUMO and IDEMSA respectively for the Taiwan dialysis market. In 1998, we took the chance to be the agent of Roche for selling Recormon Epoetin. In July of 2002, Hi-Clearance Inc. started to sell Hemodialysis related products from GAMBRO.
Market Information ( 2023/02/06 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
22.153 145.00  143.50  145.00  0.50  211 8 1
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N N Y Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.